RxDoctor Payments Data

Rachel Roberts, MD

Pain Medicine · Vestavia, ALNPI 1821438813

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Boston Scientific at 53.0% of the total.

$3,001in general payments, 2019–2025

Across 158 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Abbott$334
  • AbbVie$207
  • Scilex Pharmaceuticals Inc.$165
  • Collegium Pharmaceutical, Inc.$93
  • Nevro Corp.$92
  • plus $519 from 18 others

What the payments were for

  • Food & beverage$3,001100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,001 in reported general payments places this provider in the 65th percentile of 77 pain medicine providers in Alabama.

See all pain medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$105,588
Medicare patients
298
Services billed
1,203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,482$37,784
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen895$25,039
Gabapentin822$9,012
Lidocaine34$8,067
Naloxone Hcl94$6,245
Pregabalin242$4,774
OxycontinOxycodone Hcl11$4,431
Methocarbamol183$2,871
Oxycodone Hcl95$1,616
Tramadol Hcl127$1,087
Tizanidine Hcl136$1,013
Morphine Sulfate ErMorphine Sulfate29$838
Acetaminophen-CodeineAcetaminophen With Codeine36$721
Cyclobenzaprine Hcl54$695
Duloxetine Hcl35$557

Paid to pharmacies, not to this prescriber.

Other pain medicine in Vestavia

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →